{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:26:36Z","timestamp":1794857196980,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01120594"],"award-info":[{"award-number":["R01120594"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Novel antibacterial agents are needed to address the emergence of global antibiotic resistance. MraY is a promising candidate for antibiotic development because it is the target of five classes of naturally occurring nucleoside inhibitors with potent antibacterial activity. Although these natural products share a common uridine moiety, their core structures vary substantially and they exhibit different activity profiles. An incomplete understanding of the structural and mechanistic basis of MraY inhibition has hindered the translation of these compounds to the clinic. Here we present crystal structures of MraY in complex with representative members of the liposidomycin\/caprazamycin, capuramycin, and mureidomycin classes of nucleoside inhibitors. Our structures reveal cryptic druggable hot spots in the shallow inhibitor binding site of MraY that were not previously appreciated. Structural analyses of nucleoside inhibitor binding provide insights into the chemical logic of MraY inhibition, which can guide novel approaches to MraY-targeted antibiotic design.<\/jats:p>","DOI":"10.1038\/s41467-019-10957-9","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T10:02:56Z","timestamp":1562061776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Chemical logic of MraY inhibition by antibacterial nucleoside natural products"],"prefix":"10.1038","volume":"10","author":[{"given":"Ellene H.","family":"Mashalidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Kaeser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuma","family":"Terasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4062-5561","authenticated-orcid":false,"given":"Akira","family":"Katsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do-Yeon","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5253-0949","authenticated-orcid":false,"given":"Jiyong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0662-9921","authenticated-orcid":false,"given":"Seok-Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,2]]},"reference":[{"key":"10957_CR1","unstructured":"Tackling Drug-Resistant infections Globally: Final Report and Recommendations. Rev. Antimicrob. Resist. (2016). https:\/\/amrreview.org\/."},{"key":"10957_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrmicro3380","volume":"13","author":"JM Blair","year":"2015","unstructured":"Blair, J. M., Webber, M. A., Baylay, A. J., Ogbolu, D. O. & Piddock, L. J. Molecular mechanisms of antibiotic resistance. Nat. Rev. Microbiol 13, 42\u201351 (2015).","journal-title":"Nat. Rev. Microbiol"},{"key":"10957_CR3","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.drudis.2018.05.020","volume":"23","author":"J Hering","year":"2018","unstructured":"Hering, J., Dunevall, E., Ek, M. & Branden, G. Structural basis for selective inhibition of antibacterial target MraY, a membrane-bound enzyme involved in peptidoglycan synthesis. Drug Discov. Today 23, 1426\u20131435 (2018).","journal-title":"Drug Disco. Today"},{"key":"10957_CR4","doi-asserted-by":"publisher","first-page":"11722","DOI":"10.1002\/anie.201606396","volume":"55","author":"S Koppermann","year":"2016","unstructured":"Koppermann, S. & Ducho, C. Natural Products at Work: structural Insights into Inhibition of the Bacterial Membrane Protein MraY. Angew. Chem. Int. Ed. Engl. 55, 11722\u201311724 (2016).","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"10957_CR5","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/cmdc.201700793","volume":"13","author":"S Koppermann","year":"2018","unstructured":"Koppermann, S. et al. Insights into the target interaction of naturally occurring muraymycin nucleoside antibiotics. ChemMedChem 13, 779\u2013784 (2018).","journal-title":"ChemMedChem"},{"key":"10957_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1039\/B816215H","volume":"27","author":"M Winn","year":"2010","unstructured":"Winn, M., Goss, R. J., Kimura, K. & Bugg, T. D. Antimicrobial nucleoside antibiotics targeting cell wall assembly: recent advances in structure-function studies and nucleoside biosynthesis. Nat. Prod. Rep. 27, 279\u2013304 (2010).","journal-title":"Nat. Prod. Rep."},{"key":"10957_CR7","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.2174\/0929867322666150818103502","volume":"22","author":"S Ichikawa","year":"2015","unstructured":"Ichikawa, S., Yamaguchi, M. & Matsuda, A. Antibacterial nucleoside natural products inhibiting phospho-MurNAc-pentapeptide translocase; chemistry and structure-activity relationship. Curr. Med. Chem. 22, 3951\u20133979 (2015).","journal-title":"Curr. Med Chem."},{"key":"10957_CR8","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1128\/AAC.40.7.1640","volume":"40","author":"PE Brandish","year":"1996","unstructured":"Brandish, P. E. et al. Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli. Antimicrob. Agents Chemother. 40, 1640\u20131644 (1996).","journal-title":"Antimicrob. Agents Chemother."},{"key":"10957_CR9","first-page":"253","volume":"56","author":"Y Muramatsu","year":"2003","unstructured":"Muramatsu, Y., Ishii, M. M. & Inukai, M. Studies on novel bacterial translocase I inhibitors, A-500359s. II. Biological activities of A-500359 A, C., D. G. J. Antibiot. (Tokyo) 56, 253\u2013258 (2003).","journal-title":"Biol. Act. A-500359 A, C., D. G. J. Antibiot. (Tokyo)"},{"key":"10957_CR10","doi-asserted-by":"publisher","first-page":"7609","DOI":"10.1074\/jbc.271.13.7609","volume":"271","author":"PE Brandish","year":"1996","unstructured":"Brandish, P. E. et al. Slow binding inhibition of phospho-N-acetylmuramyl-pentapeptide-translocase (Escherichia coli) by mureidomycin A. J. Biol. Chem. 271, 7609\u20137614 (1996).","journal-title":"J. Biol. Chem."},{"key":"10957_CR11","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1016\/S0021-9258(19)81080-3","volume":"257","author":"D Duksin","year":"1982","unstructured":"Duksin, D. & Mahoney, W. C. Relationship of the structure and biological activity of the natural homologues of tunicamycin. J. Biol. Chem. 257, 3105\u20133109 (1982).","journal-title":"J. Biol. Chem."},{"key":"10957_CR12","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1128\/AAC.37.5.980","volume":"37","author":"M Inukai","year":"1993","unstructured":"Inukai, M., Isono, F. & Takatsuki, A. Selective inhibition of the bacterial translocase reaction in peptidoglycan synthesis by mureidomycins. Antimicrob. Agents Chemother. 37, 980\u2013983 (1993).","journal-title":"Antimicrob. Agents Chemother."},{"key":"10957_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nchembio.2270","volume":"13","author":"JK Hakulinen","year":"2017","unstructured":"Hakulinen, J. K. et al. MraY-antibiotic complex reveals details of tunicamycin mode of action. Nat. Chem. Biol. 13, 265\u2013267 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"10957_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41594-018-0031-y","volume":"25","author":"J Yoo","year":"2018","unstructured":"Yoo, J. et al. GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation. Nat. Struct. Mol. Biol. 25, 217\u2013224 (2018).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10957_CR15","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.cell.2018.10.037","volume":"175","author":"YY Dong","year":"2018","unstructured":"Dong, Y. Y. et al. Structures of DPAGT1 explain glycosylation disease mechanisms and advance TB antibiotic design. Cell 175, 1045\u20131058 (2018). e1016.","journal-title":"Cell"},{"key":"10957_CR16","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.drudis.2010.05.015","volume":"15","author":"S Perot","year":"2010","unstructured":"Perot, S., Sperandio, O., Miteva, M. A., Camproux, A. C. & Villoutreix, B. O. Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery. Drug Discov. Today 15, 656\u2013667 (2010).","journal-title":"Drug Disco. Today"},{"key":"10957_CR17","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1126\/science.1236501","volume":"341","author":"BC Chung","year":"2013","unstructured":"Chung, B. C. et al. Crystal structure of MraY, an essential membrane enzyme for bacterial cell wall synthesis. Science 341, 1012\u20131016 (2013).","journal-title":"Science"},{"key":"10957_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature17636","volume":"533","author":"BC Chung","year":"2016","unstructured":"Chung, B. C. et al. Structural insights into inhibition of lipid I production in bacterial cell wall synthesis. Nature 533, 557\u2013560 (2016).","journal-title":"Nature"},{"key":"10957_CR19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1021\/jo702264e","volume":"73","author":"S Hirano","year":"2008","unstructured":"Hirano, S., Ichikawa, S. & Matsuda, A. Synthesis of caprazamycin analogues and their structure\u2013activity relationship for antibacterial activity. J. Org. Chem. 73, 569\u2013577 (2008).","journal-title":"J. Org. Chem."},{"key":"10957_CR20","doi-asserted-by":"publisher","first-page":"674","DOI":"10.7164\/antibiotics.42.674","volume":"42","author":"F Isono","year":"1989","unstructured":"Isono, F., Katayama, T., Inukai, M., Haneishi, T. & Mureidomycins, A.-D. novel peptidylnucleoside antibiotics with spheroplast forming activity. III. Biological properties. J. Antibiot. (Tokyo) 42, 674\u2013679 (1989).","journal-title":"Biol. Prop. J. Antibiot. (Tokyo)"},{"key":"10957_CR21","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1128\/AAC.36.5.1024","volume":"36","author":"F Isono","year":"1992","unstructured":"Isono, F., Kodama, K. & Inukai, M. Susceptibility of Pseudomonas species to the novel antibiotics mureidomycins. Antimicrob. Agents Chemother. 36, 1024\u20131027 (1992).","journal-title":"Antimicrob. Agents Chemother."},{"key":"10957_CR22","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1016\/S0960-894X(03)00596-1","volume":"13","author":"H Hotoda","year":"2003","unstructured":"Hotoda, H. et al. Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin. Bioorg. Med. Chem. Lett. 13, 2829\u20132832 (2003).","journal-title":"Bioorg. Med Chem. Lett."},{"key":"10957_CR23","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1016\/S0960-894X(03)00597-3","volume":"13","author":"H Hotoda","year":"2003","unstructured":"Hotoda, H. et al. Synthesis and antimycobacterial activity of capuramycin analogues. Part 2: acylated derivatives of capuramycin-related compounds. Bioorg. Med. Chem. Lett. 13, 2833\u20132836 (2003).","journal-title":"Bioorg. Med Chem. Lett."},{"key":"10957_CR24","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1128\/AAC.01469-07","volume":"52","author":"VM Reddy","year":"2008","unstructured":"Reddy, V. M., Einck, L. & Nacy, C. A. In vitro antimycobacterial activities of capuramycin analogues. Antimicrob. Agents Chemother. 52, 719\u2013721 (2008).","journal-title":"Antimicrob. Agents Chemother."},{"key":"10957_CR25","first-page":"1811","volume":"53","author":"K-i Kimura","year":"1989","unstructured":"Kimura, K.-i et al. Liposidomycin C inhibits phospho-N-acetylmuramyl-pentapeptide transferase in peptidoglycan synthesis of Escherichia coli Y-10. Agric. Biol. Chem. 53, 1811\u20131815 (1989).","journal-title":"Agric. Biol. Chem."},{"key":"10957_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1021\/id5000376","volume":"1","author":"S Ichikawa","year":"2015","unstructured":"Ichikawa, S., Yamaguchi, M., Hsuan, L. S., Kato, Y. & Matsuda, A. Carbacaprazamycins: chemically stable analogues of the caprazamycin nucleoside antibiotics. ACS Infect. Dis. 1, 151\u2013156 (2015).","journal-title":"ACS Infect. Dis."},{"key":"10957_CR27","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1128\/AAC.35.2.234","volume":"35","author":"F Isono","year":"1991","unstructured":"Isono, F. & Inukai, M. Mureidomycin A, a new inhibitor of bacterial peptidoglycan synthesis. Antimicrob. Agents Chemother. 35, 234\u2013236 (1991).","journal-title":"Antimicrob. Agents Chemother."},{"key":"10957_CR28","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.1021\/jm200906r","volume":"54","author":"T Tanino","year":"2011","unstructured":"Tanino, T. et al. Mechanistic analysis of muraymycin analogues: a guide to the design of MraY inhibitors. J. Med. Chem. 54, 8421\u20138439 (2011).","journal-title":"J. Med. Chem."},{"key":"10957_CR29","doi-asserted-by":"crossref","unstructured":"Yamamoto, K., Katsuyama, A. & Ichikawa, S. Structural requirement of tunicamycin V for MraY inhibition. Bioorg. Med. Chem. Lett. 27, 1714\u20131719 (2019).","DOI":"10.1016\/j.bmc.2019.02.035"},{"key":"10957_CR30","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.bmc.2007.09.022","volume":"16","author":"S Hirano","year":"2008","unstructured":"Hirano, S., Ichikawa, S. & Matsuda, A. Design and synthesis of diketopiperazine and acyclic analogs related to the caprazamycins and liposidomycins as potential antibacterial agents. Bioorg. Med. Chem. 16, 428\u2013436 (2008).","journal-title":"Bioorg. Med Chem."},{"key":"10957_CR31","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.1016\/j.bmc.2008.03.020","volume":"16","author":"S Hirano","year":"2008","unstructured":"Hirano, S., Ichikawa, S. & Matsuda, A. Structure-activity relationship of truncated analogs of caprazamycins as potential anti-tuberculosis agents. Bioorg. Med. Chem. 16, 5123\u20135133 (2008).","journal-title":"Bioorg. Med Chem."},{"key":"10957_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.7164\/antibiotics.56.259","volume":"56","author":"Y Muramatsu","year":"2003","unstructured":"Muramatsu, Y. et al. Studies on novel bacterial translocase I inhibitors, A-500359s. III. Deaminocaprolactam derivatives of capuramycin: A-500359 E, F, H; M-1 and M-2. J. Antibiot. (Tokyo) 56, 259\u2013267 (2003).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10957_CR33","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1021\/jo202159q","volume":"77","author":"K Okamoto","year":"2012","unstructured":"Okamoto, K. et al. Total synthesis and biological evaluation of pacidamycin D and its 3\u2032-hydroxy analogue. J. Org. Chem. 77, 1367\u20131377 (2012).","journal-title":"J. Org. Chem."},{"key":"10957_CR34","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0960-894X(00)00715-0","volume":"11","author":"C Dini","year":"2001","unstructured":"Dini, C. et al. Synthesis of analogues of the O-beta-D-ribofuranosyl nucleoside moiety of liposidomycins. Part 1: contribution of the amino group and the uracil moiety upon the inhibition of MraY. Bioorg. Med. Chem. Lett. 11, 529\u2013531 (2001).","journal-title":"Bioorg. Med Chem. Lett."},{"key":"10957_CR35","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.7164\/antibiotics.46.1203","volume":"46","author":"F Isono","year":"1993","unstructured":"Isono, F. et al. Mureidomycins E and F, minor components of mureidomycins. J. Antibiot. (Tokyo) 46, 1203\u20131207 (1993).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10957_CR36","doi-asserted-by":"publisher","first-page":"595","DOI":"10.7164\/antibiotics.47.595","volume":"47","author":"S Chatterjee","year":"1994","unstructured":"Chatterjee, S. et al. Napsamycins, new Pseudomonas active antibiotics of the mureidomycin family from Streptomyces sp. HIL Y-82,11372. J. Antibiot. (Tokyo) 47, 595\u2013598 (1994).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10957_CR37","doi-asserted-by":"publisher","first-page":"10260","DOI":"10.1021\/ja017748h","volume":"124","author":"LA McDonald","year":"2002","unstructured":"McDonald, L. A. et al. Structures of the muraymycins, novel peptidoglycan biosynthesis inhibitors. J. Am. Chem. Soc. 124, 10260\u201310261 (2002).","journal-title":"J. Am. Chem. Soc."},{"key":"10957_CR38","doi-asserted-by":"publisher","first-page":"15292","DOI":"10.1002\/chem.201404775","volume":"20","author":"AP Spork","year":"2014","unstructured":"Spork, A. P. et al. Lead structures for new antibacterials: stereocontrolled synthesis of a bioactive muraymycin analogue. Chemistry 20, 15292\u201315297 (2014).","journal-title":"Chemistry"},{"key":"10957_CR39","doi-asserted-by":"crossref","unstructured":"Spork, A. P., Koppermann, S., Schier Nee Wohnig, S., Linder, R. & Ducho, C. Analogues of muraymycin nucleoside antibiotics with epimeric uridine-derived core structures. Molecules 23, 2868\u20132888 (2018).","DOI":"10.3390\/molecules23112868"},{"key":"10957_CR40","doi-asserted-by":"publisher","first-page":"8919","DOI":"10.1021\/bi8006274","volume":"47","author":"B Al-Dabbagh","year":"2008","unstructured":"Al-Dabbagh, B. et al. Active site mapping of MraY, a member of the polyprenyl-phosphate N-acetylhexosamine 1-phosphate transferase superfamily, catalyzing the first membrane step of peptidoglycan biosynthesis. Biochemistry 47, 8919\u20138928 (2008).","journal-title":"Biochemistry"},{"key":"10957_CR41","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1016\/S0968-0896(03)00270-0","volume":"11","author":"NI Howard","year":"2003","unstructured":"Howard, N. I. & Bugg, T. D. H. Synthesis and activity of 5\u2032-Uridinyl dipeptide analogues mimicking the amino terminal peptide chain of nucleoside antibiotic mureidomycin A. Bioorg. Med. Chem. 11, 3083\u20133099 (2003).","journal-title":"Bioorg. Med. Chem."},{"key":"10957_CR42","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1039\/a901287g","volume":"1","author":"C A Gentle","year":"1999","unstructured":"A Gentle, C., A. Harrison, S., Inukai, M. & D. H. Bugg, T. Structure\u2013function studies on nucleoside antibiotic mureidomycin A: synthesis of 5\u2032-functionalised uridine models. J. Chem. Soc. Perkin Trans. 1, 1287\u20131294 (1999).","journal-title":"J. Chem. Soc., Perkin Trans."},{"key":"10957_CR43","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.chembiol.2014.09.001","volume":"21","author":"MR Arkin","year":"2014","unstructured":"Arkin, M. R., Tang, Y. & Wells, J. A. Small-molecule inhibitors of protein-protein interactions: progressing toward the reality. Chem. Biol. 21, 1102\u20131114 (2014).","journal-title":"Chem. Biol."},{"key":"10957_CR44","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1016\/S0960-894X(00)00349-8","volume":"10","author":"C Dini","year":"2000","unstructured":"Dini, C. et al. Synthesis of the nucleoside moiety of liposidomycins: elucidation of the pharmacophore of this family of MraY inhibitors. Bioorg. Med. Chem. Lett. 10, 1839\u20131843 (2000).","journal-title":"Bioorg. Med Chem. Lett."},{"key":"10957_CR45","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1128\/AAC.00366-09","volume":"53","author":"BV Nikonenko","year":"2009","unstructured":"Nikonenko, B. V. et al. Activity of SQ641, a capuramycin analog, in a murine model of tuberculosis. Antimicrob. Agents Chemother. 53, 3138\u20133139 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"10957_CR46","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/AAC.01254-13","volume":"58","author":"B Nikonenko","year":"2014","unstructured":"Nikonenko, B. et al. Therapeutic efficacy of SQ641-NE against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 58, 587\u2013589 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"10957_CR47","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/ja.2014.133","volume":"68","author":"S Siricilla","year":"2015","unstructured":"Siricilla, S., Mitachi, K., Wan, B., Franzblau, S. G. & Kurosu, M. Discovery of a capuramycin analog that kills nonreplicating Mycobacterium tuberculosis and its synergistic effects with translocase I inhibitors. J. Antibiot. (Tokyo) 68, 271\u2013278 (2015).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10957_CR48","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/jac\/dkv479","volume":"71","author":"JH Moore 2nd","year":"2016","unstructured":"Moore, J. H. 2nd et al. Treatment of Clostridium difficile infection using SQ641, a capuramycin analogue, increases post-treatment survival and improves clinical measures of disease in a murine model. J. Antimicrob. Chemother. 71, 1300\u20131306 (2016).","journal-title":"J. Antimicrob. Chemother."},{"key":"10957_CR49","doi-asserted-by":"publisher","first-page":"640","DOI":"10.7164\/antibiotics.51.640","volume":"51","author":"K Kimura","year":"1998","unstructured":"Kimura, K. et al. New types of liposidomycins that inhibit bacterial peptidoglycan synthesis and are produced by Streptomyces. I. Producing organism and medium components. J. Antibiot. (Tokyo) 51, 640\u2013646 (1998).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10957_CR50","doi-asserted-by":"publisher","first-page":"647","DOI":"10.7164\/antibiotics.51.647","volume":"51","author":"K Kimura","year":"1998","unstructured":"Kimura, K. et al. New types of liposidomycins that inhibit bacterial peptidoglycan synthesis and are produced by Streptomyces. II. Isolation and structure elucidation. J. Antibiot. (Tokyo) 51, 647\u2013654 (1998).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10957_CR51","doi-asserted-by":"publisher","first-page":"281","DOI":"10.7164\/antibiotics.52.281","volume":"52","author":"Y Esumi","year":"1999","unstructured":"Esumi, Y. et al. New types of liposidomycins produced by Streptomyces that inhibit bacterial peptidoglycan synthesis. Structure elucidation of fatty acid components by tandem mass spectrometry. J. Antibiot. (Tokyo) 52, 281\u2013287 (1999).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10957_CR52","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.7164\/antibiotics.51.1099","volume":"51","author":"K Kimura","year":"1998","unstructured":"Kimura, K. et al. Selective inhibition of the bacterial peptidoglycan biosynthesis by the new types of liposidomycins. J. Antibiot. (Tokyo) 51, 1099\u20131104 (1998).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10957_CR53","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1039\/b202149h","volume":"20","author":"K-i Kimura","year":"2003","unstructured":"Kimura, K.-i & Bugg, T. D. H. Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesis. Nat. Prod. Rep. 20, 252\u2013273 (2003).","journal-title":"Nat. Prod. Rep."},{"key":"10957_CR54","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1021\/ml100057z","volume":"1","author":"T Tanino","year":"2010","unstructured":"Tanino, T. et al. Synthesis and biological evaluation of muraymycin analogues active against anti-drug-resistant bacteria. ACS Med. Chem. Lett. 1, 258\u2013262 (2010).","journal-title":"ACS Med. Chem. Lett."},{"key":"10957_CR55","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. XDS. Acta Crystallogr. D. Biol. Crystallogr. 66, 125\u2013132 (2010).","journal-title":"Biol. Crystallogr"},{"key":"10957_CR56","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1107\/S0907444913012274","volume":"69","author":"J Foadi","year":"2013","unstructured":"Foadi, J. et al. Clustering procedures for the optimal selection of data sets from multiple crystals in macromolecular crystallography. Acta Crystallogr. D. Biol. Crystallogr. 69, 1617\u20131632 (2013).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"10957_CR57","unstructured":"Tickle, I. J. et al. STARANISO. Global Phasing, Inc. (2019). http:\/\/staraniso.globalphasing.org\/cgi-bin\/staraniso.cgi."},{"key":"10957_CR58","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl Crystallogr"},{"key":"10957_CR59","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10957_CR60","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1107\/S0907444912001308","volume":"68","author":"PV Afonine","year":"2012","unstructured":"Afonine, P. V. et al. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr. D Biol. Crystallogr. 68, 352\u2013367 (2012).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10957_CR61","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1107\/S2059798316014534","volume":"72","author":"O Kovalevskiy","year":"2016","unstructured":"Kovalevskiy, O., Nicholls, R. A. & Murshudov, G. N. Automated refinement of macromolecular structures at low resolution using prior information. Acta Crystallogr. D Struct. Biol. 72, 1149\u20131161 (2016).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10957_CR62","unstructured":"The PyMOL Molecular Graphics System. Version 2.0 Schr\u00f6dinger, LLC."},{"key":"10957_CR63","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/ijch.201200096","volume":"53","author":"G Celniker","year":"2013","unstructured":"Celniker, G. et al. ConSurf: using evolutionary data to raise testable hypotheses about protein function. Isr. J. Chem. 53, 199\u2013206 (2013).","journal-title":"Isr. J. Chem."},{"key":"10957_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/srep33412","volume":"6","author":"D Das","year":"2016","unstructured":"Das, D., Walvoort, M. T., Lukose, V. & Imperiali, B. A rapid and efficient luminescence-based method for assaying phosphoglycosyltransferase enzymes. Sci. Rep. 6, 33412 (2016).","journal-title":"Sci. Rep."},{"key":"10957_CR65","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1021\/ol900458w","volume":"11","author":"M Kurosu","year":"2009","unstructured":"Kurosu, M., Li, K. & Crick, D. C. Concise synthesis of capuramycin. Org. Lett. 11, 2393\u20132396 (2009).","journal-title":"Org. Lett."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10957-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10957-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10957-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:14:41Z","timestamp":1671236081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10957-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["10957"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-10957-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,2]]},"assertion":[{"value":"20 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2917"}}